Pharma
1 min read

EU places China's Zheijiang Huahai under increased supervision

European and North American regulators last month found a second toxin in Zhejiang Huahai

REUTERS

Published On Oct 16, 2018 at 07:38 AM IST

European authorities are placing Zhejiang Huahai Pharmaceutical Co Ltd under higher supervision, the European Medicines Agency said on Monday, after an inspection revealed lapses in quality management at the drugmaker's factory in China.

European and North American regulators last month found a second toxin in Zhejiang Huahai-made blood pressure drug Valsartan that may cause cancer in humans.